Skip to main content
. 2012 Jun 6;6(6):e134–e142. doi: 10.1111/j.1750-2659.2012.00385.x

Table 4.

 Summary of studies describing intensive care unit (ICU) or critically ill patients with pandemic influenza A (H1N1pdm09)*

Study name (Size) Location and time period Case definition Ages Most common chronic conditions (%)** Obesity (%)*** Mechanical ventilation (%) ARDS (%) Death (%) Antiviral agent receipt (%)
Pediatric and adult studies
This study (n = 154) United States 
May–June 2009; September–October 2009 ICU admission Median (IQR): 
 30 years (14–47) Asthma: 24 
Neurologic disease: 17 51 58 38 24 83
Dominguez‐Cherit 12 (n = 58) Mexico 
March–June 2009 Critical illness††,††† Median (range): 44 years (10–83) Hypertension: 26 
Diabetes: 17 36 93 41 78
Kumar 13 (n = 168) Canada 
April–August 2009 Critical illness††,‡ Mean (SD) : 32 years (21) Chronic lung disease: 41 
Hypertension: 24 33 81 17 91
Miller 14 (n = 47) United States (Salt Lake County, Utah) 
May–June 2009 ICU admission Median (range): 34 years (15–62) Asthma: 30 
Diabetes: 17 74 64 17 96
ANZIC 15 (n = 722) Australia and New Zealand 
June –August 2009 ICU admission Median (IQR): 40 years (26–54) Asthma/COPD: 33 
Diabetes: 16 29 65 49‡‡ 17
Nicolay 16 (n = 77) Ireland 
July 2009–May 2010 ICU admission Median (IQR): 43 years (30–56) Asthma/COPD: 34 
Malignancy/immunosupression: 20 36 72 18
Pediatric studies
Jouvet 17 (n = 57) Canada 
April–August 2009 Critical illness††,††† Median (range): 5 years (0·08–17) Asthma: 25 
Neurologic disease: 23 68 7 77
Randolph 18 (n = 838) United States 
April 2009–April 2010 ICU admission Median (range): 6 years (0–20) Asthma: 31 
Neurologic disease: 31 67 9 97

*IQR, interquartile range; SD, standard deviation; COPD, chronic obstructive pulmonary disease.

**Excludes obesity and history of smoking.

***This study, Dominguez‐Cherit, Kumar, and Miller report patients with body mass index (BMI) >30; ANZIC and Nicolay report patients with BMI >35.

Includes confirmed pH1N1cases only.

††Defined as those (1) admitted to ICU, (2) requiring mechanical ventilation, (3) having a fraction of inspired oxygen (FIO2) greater than or equal to 60%, or (4) receiving intravenous infusion of inotropic or vasopressor medication.

†††Includes confirmed, probable, and suspected pH1N1 cases.

Includes confirmed and probable pH1N1 cases.

‡‡Includes patients with ARDS and viral pneumonitis.

ARDS, acute respiratory distress syndrome; pH1N1, pandemic influenza A (H1N1pdm09).